Question 1

What is China Pharma Holdings, Inc.'s WACC?

Accepted Answer

China Pharma Holdings, Inc. (CPHI) has a Weighted Average Cost of Capital (WACC) of 8.26%. This is calculated using a Cost of Equity of 8.53% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 2.39%, with an equity weight of 95.62% in the capital structure.

Question 2

Is China Pharma Holdings, Inc.'s WACC high or low?

Accepted Answer

China Pharma Holdings, Inc.'s WACC of 8.26% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is China Pharma Holdings, Inc.'s WACC calculated?

Accepted Answer

China Pharma Holdings, Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.53% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 2.39%. The capital structure is 95.62% equity and 4.38% debt.

China Pharma Holdings, Inc. (CPHI) — WACC 分析

WACC 构成

解读

China Pharma Holdings, Inc.（CPHI）WACC：8.26%

WACC计算器

China Pharma Holdings, Inc.（CPHI） WACC 解读

CPHI 公司分析

CPHI DCF 估值

继续做同行对比